Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The study page remains inaccessible and shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T10:00:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T10:57:30.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now displays ClinicalTrials.gov revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T12:59:11.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the study record still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T12:34:27.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual content and leaving a simple Home link. This means the record is temporarily inaccessible and trial details are not viewable on this page.
    Difference
    19%
    Check dated 2026-09-19T18:36:47.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    NIH funding entries for 2017 and 2023 were added to the page. The revision history now shows v3.6.6, and the previous v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-29T19:39:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.